New compounds for inhibiting differentiation of osteoclast and pharmaceutical composition comprising thereof
申请人:METACINE, INC.
公开号:US20140031563A1
公开(公告)日:2014-01-30
New compounds and pharmaceutical compositions comprising active ingredients having inhibition effects on osteoclast differentiation are provided. The pharmaceutical compositions comprising the new compounds can be used as medicines for treating metabolic bone diseases such as bone metastatic cancer, solid cancer bone metastasis, musculoskeletal complication by solid cancer bone metastasis, hypercalcemia by malignant tumor, multiple myeloma, primary bone tumor, osteoporosis, rheumatoid arthritis, osteoarthritis, periodontal disease, inflammatory resorption of alveolar bone, inflammatory resorption of bone, and Paget's disease.
提供了包含对破骨细胞分化具有抑制作用的活性成分的新化合物和制药组合物。包含这些新化合物的制药组合物可用作治疗代谢性骨疾病的药物,如骨转移癌、实体癌骨转移、实体癌骨转移引起的肌肉骨骼并发症、恶性肿瘤引起的高钙血症、多发性骨髓瘤、原发性骨肿瘤、骨质疏松症、类风湿性关节炎、骨关节炎、牙周病、牙槽骨炎炎性吸收、骨炎炎性吸收和帕金森病。